MODD Modular Medical, Inc.
Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1074871 · Fiscal year ends 03/31
Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-12.9%
TTM EPS YoY71.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-270.8%
ROA-212.7%
ROIC (approx.)-430.1%
Asset turnover—
Leverage & solvency
Liabilities / assets10.3%
Debt / equity0.00x
Current ratio4.46x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.92x
Accruals ratio-16.5%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q22026-09-30 | 2027Q12026-06-30 | 2026Q4*2026-03-31 | 2026Q32025-12-31 | 2026Q22025-09-30 | 2026Q12025-06-30 | 2025Q4*2025-03-31 | 2025Q32024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | — | — | — | — | — |
| R&D expense | $3.93M | $4.37M | $3.84M | $5.41M | $5.59M | $5.13M | $3.94M | $3.85M |
| SG&A expense | $3.21M | $2.17M | $1.84M | $1.84M | $2.24M | $1.67M | $1.04M | $1.00M |
| Operating income | -$7.14M | -$6.54M | -$5.68M | -$7.24M | -$7.83M | -$6.80M | -$4.98M | -$4.85M |
| Pretax income | -$7.10M | — | -$6.39M | -$7.36M | -$7.79M | — | -$4.93M | -$4.80M |
| Income tax | $2,000 | — | $0 | $0 | $2,000 | — | $0 | $0 |
| Net income | -$7.10M | -$6.49M | -$6.39M | -$7.36M | -$7.79M | -$6.70M | -$4.93M | -$4.80M |
| EBITDA | -$6.69M | -$6.04M | -$5.24M | -$6.81M | -$7.44M | -$6.39M | -$4.65M | -$4.57M |
| EPS (basic) | -0.90 | -1.19 | — | -0.11 | -4.21 | -3.70 | — | -0.13 |
| EPS (diluted) | -0.90 | -1.19 | — | -0.11 | -4.21 | -3.70 | — | -0.13 |
| Weighted avg. shares (diluted) | 7.93M | 5.45M | — | 65.93M | 1.85M | 1.81M | — | 37.81M |
| Balance sheet | ||||||||
| Cash & equivalents | $5.10M | $3.92M | $6.94M | $2.94M | $5.32M | $7.52M | $13.10M | $6.99M |
| Current assets | $5.86M | $4.84M | $7.54M | $3.47M | $5.95M | $8.29M | $13.52M | $7.33M |
| PP&E, net | $6.69M | $7.09M | $6.87M | $6.33M | $6.46M | $5.21M | $4.45M | $3.96M |
| Total assets | $12.73M | $12.25M | $14.83M | $10.26M | $12.97M | $14.17M | $18.73M | $12.15M |
| Current liabilities | $1.31M | $1.49M | $1.87M | $2.18M | $4.04M | $2.05M | $1.26M | $1.38M |
| Total liabilities | $1.31M | $1.49M | $1.87M | $4.38M | $4.21M | $2.33M | $1.66M | $1.89M |
| Shareholders' equity | $11.42M | $10.76M | $12.96M | $5.88M | $8.77M | $11.84M | $17.08M | $10.26M |
| Shares outstanding | 9.50M | 5.57M | 4.66M | 77.70M | 61.17M | 55.27M | 1.79M | 40.66M |
| Cash flow statement | ||||||||
| Operating cash flow | -$6.28M | -$5.97M | -$5.82M | -$7.16M | -$5.41M | -$5.37M | -$4.31M | -$4.10M |
| Capital expenditure | $88,000 | $688,000 | $1.00M | $1.22M | $771,000 | $934,000 | $948,000 | $542,000 |
| Free cash flow | -$6.37M | -$6.66M | -$6.82M | -$8.38M | -$6.18M | -$6.31M | -$5.26M | -$4.64M |
| Investing cash flow | -$88,000 | -$688,000 | -$1.00M | -$1.22M | -$771,000 | -$934,000 | -$948,000 | -$542,000 |
| Financing cash flow | $7.55M | $3.64M | $10.82M | $6.00M | $3.98M | $733,000 | $11.37M | $7.73M |
| Depreciation & amortization | $447,000 | $501,000 | $441,000 | $430,000 | $391,000 | $410,000 | $326,000 | $281,000 |
| Stock-based compensation | $307,000 | $447,000 | -$293,000 | $2,000 | $4,000 | $724,000 | $374,000 | $5,000 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.